Does Favipiravir Reduce Mortality in Patients with COVID-19 ARDS and Severe Pneumonia?

• Auteurs principaux: Khin Zar Li Aung (Auteur), Rabia Yılmaz (Auteur), Ezgi Güngördü (Auteur), Sinan Aşar (Auteur), Yasemin Tekdos Şeker (Auteur)
• Format: Livre
• Publié: Galenos Yayinevi, 2021-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Objective:Although there is no antiviral treatment specific to the virus, favipiravir has entered the treatment routine as an antiviral in our country in May 2020. In this study, in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acute respiratory distress syndrome (ARDS)...